Cocrystal Pharma (COCP) Assets Average (2011 - 2026)

Cocrystal Pharma (COCP) has 14 years of Assets Average data on file, last reported at $8.6 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 28.93% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (down 28.93% YoY), and the FY2025 full-year result was $11.6 million, down 48.19% from the prior year.
• Assets Average retreated to $8.6 million in Q1 2026, from $10.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $77.4 million in Q1 2022 to a low of $8.6 million in Q1 2026.
• A 5-year average of $30.2 million and a median of $28.9 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 43.18% in 2022 and tumbled 60.17% in 2025, its largest moves.
• Tracing COCP's Assets Average over 5 years: stood at $43.2 million in 2022, then declined by 26.15% to $31.9 million in 2023, then sank by 53.52% to $14.8 million in 2024, then tumbled by 32.1% to $10.1 million in 2025, then slipped by 14.98% to $8.6 million in 2026.
• Business Quant data shows COCP's Assets Average at $8.6 million in Q1 2026, $10.1 million in Q4 2025, and $9.5 million in Q3 2025.